S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
NASDAQ:ENTL

(ENTL) (ENTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$24.00
$24.00
50-Day Range
$24.00
$24.06
52-Week Range
$11.47
$25.58
Volume
N/A
Average Volume
178,331 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ENTL stock logo

About (ENTL) Stock (NASDAQ:ENTL)

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

ENTL Stock News Headlines

This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Lask entlässt Trainer Sageder
See More Headlines
Receive ENTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ENTL) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2016
Today
4/18/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ENTL
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Robert S. White
    President, Chief Executive Officer, Director
  • Brent A. Moen
    Chief Financial Officer, Corporate Secretary
  • Michael H. Rosenthal
    Chief Operating Officer
  • Jonelle R. Burnham
    Chief Compliance Officer, Vice President, General Counsel
  • Stephen R. Paidosh
    Vice President, Operations
  • Thomas D. Williamson
    Vice President - Sales
  • Kevin L. Mensink
    Vice President of Marketing
  • Martha J. Christian
    Vice President, Reimbursement
  • Timothy B. Petrick
    Vice President, Research and Development
  • Brian E. Farley
    Non-Executive Chairman of the Board

ENTL Stock Analysis - Frequently Asked Questions

How were (ENTL)'s earnings last quarter?

(ENTL) (NASDAQ:ENTL) posted its quarterly earnings results on Thursday, November, 3rd. The medical technology company reported ($0.50) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by $0.13. The medical technology company had revenue of $17.90 million for the quarter, compared to analysts' expectations of $17.93 million. The company's revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.32) EPS.

What other stocks do shareholders of (ENTL) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ENTL) investors own include Intersect ENT (XENT), (RLYP) (RLYP), Twitter (TWTR), ACADIA Pharmaceuticals (ACAD), AcelRx Pharmaceuticals (ACRX), Aimmune Therapeutics (AIMT), Broadcom (AVGO), Aircastle (AYR) and Alibaba Group (BABA).

When did (ENTL) IPO?

(ENTL) (ENTL) raised $70 million in an IPO on Friday, January 30th 2015. The company issued 4,400,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

This page (NASDAQ:ENTL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners